2023-07-28 11:55:37 ET
- ImmunoGen ( NASDAQ: IMGN ) is scheduled to announce Q2 earnings results on Monday, July 31st, before market open.
- The consensus EPS Estimate is -$0.15 (+37.5% Y/Y) and the consensus Revenue Estimate is $46.6M (+228.2% Y/Y).
- Over the last 2 years, IMGN has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 10 upward revisions and 0 downward. Revenue estimates have seen 8 upward revisions and 0 downward.
For further details see:
ImmunoGen Q2 2023 Earnings Preview